https://www.biospace.com/phasebio-pulls-the-plug-on-phase-iib-pulmonary-arterial-hypertension-trial
PhaseBio Pulls the Plug on Phase IIb Pulmonary Arterial Hypertension Trial - BioSpace
Dec 23, 2021 - PhaseBio's move to suspend its Phase IIb trial of pemziviptadil is due to the effect of COVID-19 on manufacturing, associated drug supply, and the rate of...
the plugphase iib
https://www.biospace.com/rexahn-pharmaceuticals-inc-to-initiate-zoraxel-phase-iib-trial-for-treatment-of-erectile-dysfunction
Rexahn Pharmaceuticals, Inc. to Initiate Zoraxel Phase IIb Trial for Treatment of Erectile...
https://www.biospace.com/wex-pharmaceuticals-inc-release-tectin-tm-phase-iib-iii-interim-analysis-expected
Wex Pharmaceuticals Inc. Release: Tectin "TM" Phase IIB/III Interim Analysis Expected - BioSpace
https://www.biospace.com/oryzon-announces-topline-results-from-phase-iib-portico-study-of-vafidemstat-in-borderline-personality-disorder-bpd
ORYZON Announces Topline Results from Phase IIb PORTICO Study of Vafidemstat in Borderline...
Jan 6, 2024 - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a...
https://www.biospace.com/creabilis-sa-announces-start-of-phase-iib-trial-of-trka-kinase-inhibitor-ct327-in-psoriasis
Creabilis SA Announces Start of Phase IIb Trial of TrkA Kinase Inhibitor CT327 in Psoriasis -...
https://www.mayo.edu/research/clinical-trials/cls-20590376
Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo...
Learn more about services at Mayo Clinic.
https://www.biospace.com/teva-pharmaceutical-industries-announces-positive-results-for-tev-48125-in-phase-iib-chronic-migraine-study-meeting-primary-and-secondary-endpoints
Teva Pharmaceutical Industries Announces Positive Results For TEV-48125 In Phase IIb Chronic...
https://www.prnewswire.co.uk/news-releases/asarina-pharma-recruits-patients-for-phase-iib-trial-of-sepranolone-worlds-first-treatment-targeting-678745733.html
Asarina Pharma Recruits Patients for Phase IIB Trial of Sepranolone, World's First Treatment...
/PRNewswire/ -- Patient enrolment is expected to be high for the Phase IIB clinical trial of Sepranolone, driven by strong medical need for a therapy that...
https://investingnews.com/anavex-life-sciences-presents-new-data-from-its-ad-004-phase-iib-iii-trial-at-ad-pd-2026-conference-demonstrating-consistent-correlation-between-the-treatment-effect-of-oral-blarcamesine-and-preservat/
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference...
Mar 23, 2026 - New data show brain-volume preservation correlates with patient outcomes Long-term clinical data indicate 77.4 weeks (17.8 months) time saved with oral...
https://www.mayo.edu/research/clinical-trials/cls-20454815
A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic
Learn more about services at Mayo Clinic.
https://www.prnewswire.co.uk/news-releases/index-pharmaceuticals-concludes-well-attended-investigators-meeting-for-the-phase-iib-study-conduct-616792684.html
InDex Pharmaceuticals Concludes Well Attended Investigators' Meeting for the Phase IIb Study Conduct
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company hosted a well attended investigators' meeting for the CONDUCT study...
https://www.businesswire.com/news/home/20240530827437/en/ChromaTan-Receives-a-%242M-Phase-IIB-NIH-Grant-to-Develop-a-Fully-Integrated-Continuous-Purification-of-AAV-via-BioRMB-a-Column-Free-Steady-State-Continuous-Elution-Purification-Platform.
ChromaTan Receives a $2M Phase IIB NIH Grant to Develop a Fully Integrated Continuous Purification...
ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce the award of NIH IIB grant ...
https://www.biospace.com/first-patient-in-treatment-in-rhovac-s-clinical-phase-iib-study-in-united-kingdom
First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom - BioSpace
Jan 7, 2021 - RhoVac AB ("RhoVac") announces today, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb study in...
https://www.prnewswire.com/news-releases/moebius-medical-announces-dosing-of-first-patient-in-global-phase-iib-clinical-trial-of-mm-ii-a-novel-treatment-for-knee-osteoarthritis-pain-301229083.html
Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II, a...
/PRNewswire/ -- Israel-based Moebius Medical today announced that the first patient has been dosed in its Phase IIb clinical trial of MM-II, a novel...
https://finviz.com/news/339156/anavex-life-sciences-presents-new-data-from-its-ad-004-phase-iibiii-trial-at-adpd-2026-conference-demonstrating-consistent-correlation-between-the-treatment-effect-of-oral-blarcamesine-and-preservation-of-brain-volume-in-early-alzheimers-disease
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference...
Stock screener for investors and traders, financial visualizations.